J. Voorham

First name

J.

Last name

Voorham

van Boven, J., Benhaddi, H., Roche, N., Bjermer, L., Miravitlles, M., Voorham, J., & Price, D. (2017). Real-world cost effectiveness comparison of symbicort turbuhaler and duoresp spiromax in UK patients with asthma or chronic obstructive pulmonary disease. Value in Health.

View

Voorham, J., Roche, N., Benhaddi, H., van der Tol, M., Carter, V., van Boven, J. F. M., et al. (2018). Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK. BMJ Open. http://doi.org/10.1136/bmjopen-2018-022051

View

Price, D. B., Trudo, F., Voorham, J., Xu, X., Kerkhof, M., Jie, L. Z., & Tran, T. N. (2018). Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. http://doi.org/10.2147/jaa.s176026

View

Voorham, J., Xu, X., Price, D. B., Golam, S., Davis, J., Ling, Z. J., et al. (2019). Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma. Allergy. http://doi.org/10.1111/all.13556

View

Kerkhof, M., Voorham, J., Dorinsky, P., Cabrera, C., Darken, P., Kocks, J. W., et al. (2020). Association between COPD exacerbations and lung function decline during maintenance therapy. Thorax. http://doi.org/10.1136/thoraxjnl-2019-214457

View